These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25146491)

  • 1. Differential modification of genetic susceptibility to childhood eczema by two probiotics.
    Morgan AR; Han DY; Wickens K; Barthow C; Mitchell EA; Stanley TV; Dekker J; Crane J; Ferguson LR
    Clin Exp Allergy; 2014 Oct; 44(10):1255-65. PubMed ID: 25146491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors.
    Marlow G; Han DY; Wickens K; Stanley T; Crane J; Mitchell EA; Dekker J; Barthow C; Fitzharris P; Ferguson LR; Morgan AR
    Pediatr Allergy Immunol; 2015 May; 26(3):262-271. PubMed ID: 25779902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
    Wickens K; Stanley TV; Mitchell EA; Barthow C; Fitzharris P; Purdie G; Siebers R; Black PN; Crane J
    Clin Exp Allergy; 2013 Sep; 43(9):1048-57. PubMed ID: 23957340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.
    Wickens K; Black PN; Stanley TV; Mitchell E; Fitzharris P; Tannock GW; Purdie G; Crane J;
    J Allergy Clin Immunol; 2008 Oct; 122(4):788-794. PubMed ID: 18762327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
    Wickens K; Black P; Stanley TV; Mitchell E; Barthow C; Fitzharris P; Purdie G; Crane J
    Clin Exp Allergy; 2012 Jul; 42(7):1071-9. PubMed ID: 22702506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years.
    Wickens K; Barthow C; Mitchell EA; Kang J; van Zyl N; Purdie G; Stanley T; Fitzharris P; Murphy R; Crane J
    Pediatr Allergy Immunol; 2018 Dec; 29(8):808-814. PubMed ID: 30430649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
    Murphy R; Morgan XC; Wang XY; Wickens K; Purdie G; Fitzharris P; Otal A; Lawley B; Stanley T; Barthow C; Crane J; Mitchell EA; Tannock GW
    Benef Microbes; 2019 Feb; 10(1):5-17. PubMed ID: 30574802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two probiotics in follow-on formula:
    Dekker J; Quilter M; Qian H
    Benef Microbes; 2022 Oct; 13(4):341-354. PubMed ID: 36004715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema.
    Wickens K; Barthow C; Mitchell EA; Stanley TV; Purdie G; Rowden J; Kang J; Hood F; van den Elsen L; Forbes-Blom E; Franklin I; Barnes P; Fitzharris P; Maude RM; Stone P; Abels P; Murphy R; Crane J
    Pediatr Allergy Immunol; 2018 May; 29(3):296-302. PubMed ID: 29415330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.
    Barthow C; Wickens K; Stanley T; Mitchell EA; Maude R; Abels P; Purdie G; Murphy R; Stone P; Kang J; Hood F; Rowden J; Barnes P; Fitzharris P; Craig J; Slykerman RF; Crane J
    BMC Pregnancy Childbirth; 2016 Jun; 16(1):133. PubMed ID: 27255079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
    Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial.
    Schmidt RM; Pilmann Laursen R; Bruun S; Larnkjaer A; Mølgaard C; Michaelsen KF; Høst A
    Pediatr Allergy Immunol; 2019 May; 30(3):335-340. PubMed ID: 30790361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early probiotic supplementation on childhood cognition, behaviour and mood a randomised, placebo-controlled trial.
    Slykerman RF; Kang J; Van Zyl N; Barthow C; Wickens K; Stanley T; Coomarasamy C; Purdie G; Murphy R; Crane J; Mitchell EA
    Acta Paediatr; 2018 Dec; 107(12):2172-2178. PubMed ID: 30246890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema.
    Kim HK; Rutten NB; Besseling-van der Vaart I; Niers LE; Choi YH; Rijkers GT; van Hemert S
    Benef Microbes; 2015; 6(6):783-90. PubMed ID: 26565082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
    Zhou JS; Gill HS
    Int J Food Microbiol; 2005 Aug; 103(1):97-104. PubMed ID: 16084270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood.
    P K; M K; K K; T L; M K
    Allergol Immunopathol (Madr); 2014; 42(6):560-7. PubMed ID: 24439655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.
    Prescott SL; Wickens K; Westcott L; Jung W; Currie H; Black PN; Stanley TV; Mitchell EA; Fitzharris P; Siebers R; Wu L; Crane J;
    Clin Exp Allergy; 2008 Oct; 38(10):1606-14. PubMed ID: 18631345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
    Zhou JS; Pillidge CJ; Gopal PK; Gill HS
    Int J Food Microbiol; 2005 Feb; 98(2):211-7. PubMed ID: 15681048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.
    Gore C; Custovic A; Tannock GW; Munro K; Kerry G; Johnson K; Peterson C; Morris J; Chaloner C; Murray CS; Woodcock A
    Clin Exp Allergy; 2012 Jan; 42(1):112-22. PubMed ID: 22092692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant.
    Rautava S; Kainonen E; Salminen S; Isolauri E
    J Allergy Clin Immunol; 2012 Dec; 130(6):1355-60. PubMed ID: 23083673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.